Apr 9 |
Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices
|
Apr 9 |
Medicare to reimburse for Vivos CARE sleep apnea devices
|
Apr 9 |
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
|
Apr 9 |
Vivos Therapeutics files to sell 1.73M shares of common stock for holders
|
Apr 1 |
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript
|
Apr 1 |
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
|
Mar 31 |
Vivos Therapeutics Full Year 2023 Earnings: Misses Expectations
|
Mar 29 |
Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript
|
Mar 28 |
Vivos Therapeutics reports Q4 results
|
Mar 28 |
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
|